Three Names Stand Out In Search For Quality ADRs

June 2012
Investors Business Daily;6/11/2012, pB08
Friday was Day 5 of a rally attempt for S&P 500 and Day 4 for the other U.S. indexes, so it's time to gauge where U.S.-listed ADRs stand in the event the market notches a follow-through day.


Related Articles

  • Patient versus Healthcare Professional Spontaneous Adverse Drug Reaction Reporting. Inch, Jackie; Watson, Margaret C.; Anakwe-Umeh, Stella // Drug Safety;2012, Vol. 35 Issue 10, p807 

    Background: Increasing numbers of national pharmacovigilance schemes are accepting adverse drug reaction (ADR) reports from patients. The extent to which patient ADR reports contribute to pharmacovigilance requires comparisons to be made with reports from healthcare professionals (HCPs)....

  • National ADR Monitoring System in China. Hou, Yongfang; Li, Xinling; Wu, Guizhi; Ye, Xiaofei // Drug Safety;Nov2016, Vol. 39 Issue 11, p1043 

    It has been more than 25 years since an adverse drug reaction (ADR) monitoring agency was first established in China. In the past few years, the National ADR Monitoring System (NADRMS) has developed rapidly in the country. However, this system has not been reviewed in detail in the...

  • Is there a brand that will take a stand? Stein, Jason // Automotive News Europe;10/1/2007, Vol. 12 Issue 20, p10 

    The author reflects on which automobile manufacturer stands for the three brand characteristics, namely, quality, safety and environmental friendliness. According to Jacques Rivoal of Renault, the company is going on the offensive with a new brand campaign. He asserts that in a world where it is...

  • ADR in youth and intercollegiate athletics. Fried, Gil; Hiller, Michael // Brigham Young University Law Review;1997, Vol. 1997 Issue 3, p631 

    Presents information on the use of Alternative Dispute Resolution (ADR) techniques to resolve athletic conflicts. Names of three organizations that provide ADR assistance for sports-related disputes; General goal of ADR; Information on mediation as third-party assisted negotiation.

  • CA's New CEO Focused On Igniting Sales. PAUL WHITFIELD // Investors Business Daily;7/30/2013, pB06 

    Three things stand out for big-cap

  • ADR.  // Taber's Cyclopedic Medical Dictionary;2005, p47 

    The acronym ADR is presented, which stands for adverse drug reaction.

  • THE MONEY PIT. Morell, Parker // Saturday Evening Post;10/14/1939, Vol. 212 Issue 16, p6 

    The article focuses on the search for The Money Pit, a mystery treasure believed to be located in Oak Island, Nova Scotia. The story of the mystery treasure dates back to a day in 1795, when three young Nova Scotians, named Smith, Vaughan and MacGinnies, reached Oak Island on their canoe. They...

  • ROMANCING THE STONES. Williams, Mina // WWD: Women's Wear Daily;WWD Scoop, Vol. 192 Issue 46, p112 

    The article focuses on the establishment of Cayuse Vineyards in Walla Walla, Washington. Winemaker Christophe Baron planted his vineyards, seeking to seize the radiant heat of the rocky soil in the region to further ripen the grapes and to impart a unique mineral quality to his wines. Cayuse...

  • A Study On Adverse Drug Reactions At A Tertiary Care Teaching Hospital. Palanisamy, Sivanandy; Kumaran, Kottur S. G. Arul; Rajasekaran, Aiyalu // International Journal of Pharmacy Teaching & Practices (IJPTP);2011, Vol. 2 Issue 3, p96 

    Objective: The main objectives of the study were to assess the incidence and pattern of ADRs, identifying co-morbidities, past, present illness, assess causality, and offending drugs, monitoring, documenting suspected adverse drug reaction(s) and estimate the cost involved. Methods: A...

  • Toward Enhanced Pharmacovigilance Using Patient-Generated Data on the Internet. White, R W; Harpaz, R; Shah, N H; DuMouchel, W; Horvitz, E // Clinical Pharmacology & Therapeutics;Aug2014, Vol. 96 Issue 2, p239 

    The promise of augmenting pharmacovigilance with patient-generated data drawn from the Internet was called out by a scientific committee charged with conducting a review of the current and planned pharmacovigilance practices of the US Food and Drug Administration (FDA). To this end, we present a...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics